AGE Insider Trading Activity and SEC Form 4 Filings
AGE insider trading summary
No open-market insider purchases or sales of AgeX Therapeutics, Inc. (AGE) have been reported on SEC Form 4 in the past 12 months.
Latest AGE insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Aug 13, 2019 | Juvenescence Ltd | 10% Owner | Buy | $0 (19,000 @ $0.00) |
| Dec 10, 2018 | Michael D West | Chief Executive Officer | Buy | $15K (4,000 @ $3.86) |
| Jul 5, 2007 | Mary Veranth Atkin | Subsidiary Officer | Sell | $427K (5,000 @ $85.30) |
| Mar 29, 2007 | Vicki B Escarra | Director | Buy | $22K (320 @ $68.75) |
| Dec 27, 2006 | Vicki B Escarra | Director | Buy | $7K (110 @ $64.24) |
| Oct 4, 2006 | Eugene E Carter | Director | Sell | $438K (8,000 @ $54.80) |
| Oct 3, 2006 | Eugene E Carter | Director | Sell | $107K (2,000 @ $53.60) |
| Sep 21, 2006 | Thomas H Martin Jr | Subsidiary Officer | Sell | $76K (1,421 @ $53.55) |
| Jul 6, 2006 | Eugene E Carter | Director | Sell | $275K (5,000 @ $54.90) |
| Jul 3, 2006 | Eugene E Carter | Director | Sell | $276K (5,000 @ $55.20) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.